- Home
- MLYS vs KC Comparison
MLYS vs KC Comparison
Compare MLYS & KC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- KC
- Stock Information
- Founded
- MLYS 2019
- KC 2012
- Country
- MLYS United States
- KC China
- Employees
- MLYS N/A
- KC N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- KC Computer Software: Prepackaged Software
- Sector
- MLYS Health Care
- KC Technology
- Exchange
- MLYS Nasdaq
- KC Nasdaq
- Market Cap
- MLYS 590.3M
- KC 530.8M
- IPO Year
- MLYS 2023
- KC 2020
- Fundamental
- Price
- MLYS $13.88
- KC $3.90
- Analyst Decision
- MLYS Strong Buy
- KC Strong Buy
- Analyst Count
- MLYS 2
- KC 5
- Target Price
- MLYS $30.00
- KC $4.12
- AVG Volume (30 Days)
- MLYS 122.0K
- KC 2.6M
- Earning Date
- MLYS 11-05-2024
- KC 11-19-2024
- Dividend Yield
- MLYS N/A
- KC N/A
- EPS Growth
- MLYS N/A
- KC N/A
- EPS
- MLYS N/A
- KC N/A
- Revenue
- MLYS N/A
- KC $965,352,762.00
- Revenue This Year
- MLYS N/A
- KC $9.57
- Revenue Next Year
- MLYS N/A
- KC $9.26
- P/E Ratio
- MLYS N/A
- KC N/A
- Revenue Growth
- MLYS N/A
- KC N/A
- 52 Week Low
- MLYS $5.85
- KC $2.02
- 52 Week High
- MLYS $16.91
- KC $5.80
- Technical
- Relative Strength Index (RSI)
- MLYS 70.82
- KC 80.91
- Support Level
- MLYS $11.73
- KC $3.57
- Resistance Level
- MLYS $12.27
- KC $4.15
- Average True Range (ATR)
- MLYS 0.61
- KC 0.23
- MACD
- MLYS 0.19
- KC 0.18
- Stochastic Oscillator
- MLYS 98.50
- KC 87.37
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.
About KC Kingsoft Cloud Holdings Limited
Kingsoft Cloud Holdings Ltd is an independent cloud service provider in China. It provides integrated cloud-based services including cloud computing, storage, and delivery. Its products and services are Safety, database, AI, hybrid cloud and others. Its solutions are medical, government affairs, finance, media, Educate, game, Transportation and Logistics, Audio, and video.